- Home
- SPRY vs NFGC Comparison
SPRY vs NFGC Comparison
Compare SPRY & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | NFGC |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.5M | 760.5M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPRY | NFGC |
|---|---|---|
| Price | $8.56 | $1.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $84,278,000.00 | N/A |
| Revenue This Year | $87.40 | $3,542.00 |
| Revenue Next Year | $81.64 | $118.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.66 | $1.39 |
| 52 Week High | $18.63 | $3.59 |
Technical Indicators
Market Signals| Indicator | SPRY | NFGC |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 33.15 |
| Support Level | $7.82 | N/A |
| Resistance Level | $8.61 | $2.12 |
| Average True Range (ATR) | 0.59 | 0.11 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 51.45 | 1.14 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Companies exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).